Optimization of the Management of Non-Traumatic Intracerebral Hemorrhage (OPT-ICH)

Recruiting Observational Study
Intracerebral Hemorrhage
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
600 (estimated)
Sponsor
University Hospital, Tours · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Intracerebral non-traumatic intraparenchymal hemorrhages (ICH) account for 15 to 20% of strokes. One third of the patients dies within the month following ICH, and survivors often experience residual disability with a high risk of recurrent ICH, other serious vascular events, and neurological complications such as epilepsy and dementia. Encouraging but preliminary data suggest a favorable trend in…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * aged over 18 years * emergency admission to the University Hospital of Tours * having an ICH on imaging performed upon admission (CT scan or MRI) at the University Hospital of Tours Exclusion criteria : \- Patient who has given their opposition to the collection of their dat…
Contacts

Marco PASI, MD, PHD

+33 0247478024

M.PASI@chu-tours.fr

CONTACT